Genentech 4HER Patient Support App

Support for people with HER2+ breast cancer

Designed by Genentech, with some content developed in collaboration with Breastcancer.org, this easy-to-use app is designed for women with HER2+ breast cancer. Whether you’d like to get information, relax with a soothing meditation, or connect with others for support, 4HER is here for you.

Download now from the App Store® or Google Play.

Learn

We’ve collaborated with Breastcancer.org to bring you information about HER2+ breast cancer, as well as health and lifestyle tips and additional resources.

Play

Play a fun game to help pass the time during infusions or whenever you need a little diversion.

Relax

Take a little break from the day with soothing, guided meditations.
Three meditations to choose from: 5, 10, and 20 minutes in length.

Connect

Connect with other patients outside of the app and find resources to get information and support.*

  • Connect with other breast cancer patients outside the app
  • Speak to a Genentech financial support specialist
  • Learn about cancer support groups

*To protect your privacy, you control what information you want to share. Genentech does not have visibility into the interactions of those participating in Patient Connect. Participants in this feature are connecting directly with each other outside Genentech systems. 

Download the free app from Genentech on the App Store® or Google Play.

This information is not meant to replace the advice of your healthcare team. Please talk with your healthcare team about your medical condition and treatment. Only your doctor and healthcare team can give you medical advice.

Apple, the Apple logo, and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App store is a registered trademark of Apple Inc. Google Play is a trademark of Google Inc. 

KADCYLA Access Solutions

If you would like help paying for KADCYLA, there may be options to help you get the medicine you need.

HERConnection Program

A free program that provides information and resources to patients receiving KADCYLA.